.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Key Updates in the Management of Acute Myeloid Leukemia and Their Application in Clinical Practice

EP. 1: Risk Classification, Mutational Analysis Are Key in Informing AML Management

April 14th 2023

During an OncLive® workshop titled Key Updates in the Management of Acute Myeloid Leukemia and Their Application in Clinical Practice, moderated by Naval Daver, MD, faculty reviewed updates to the classification of acute myeloid leukemia and its effects on the treatment paradigm and provided insight on the management of adverse-risk and secondary acute myeloid leukemia.

EP. 2: Dr Eisfeld on Updated Guidelines for the Classification of AML

April 18th 2023

Ann-Kathrin Eisfeld, MD, discusses recent changes to the classification of acute myeloid leukemia, and potential challenges accompanying these new guidelines.

EP. 3: Dr Eisfeld on Timing of Molecular Testing and the Start of Treatment in AML

May 25th 2023

Ann-Kathrin Eisfeld, MD, discusses factors to consider when deciding whether to start treatment right away or wait for molecular testing results in patients with acute myeloid leukemia.